CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The PRECEDE project focuses on improving early detection of pancreatic cancer by personalizing the CA19.9 biomarker test. Using an algorithm that learns individual baseline levels, it aims to enhance sensitivity and specificity for screening high-risk individuals, ultimately leading to earlier diagnosis and better trea…
PRECEDE (PancREatic Cancer Early DEtection):
Pancreatic cancer is a devastating disease.
Five year survival is only 3% and this figure has not changed for 40 years. A recent EU study has shown that this is the only cancer who’s incidence and mortality are set to increase.
By the time patients present with symptoms, the disease is usually advanced and untreatable.
The most effective way to improve survival would be to diagnose the disease earlier when therapy is more likely to be successful.CA19.…
ABCODIA LIMITED
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
